Peng Hui, Xing Yan-Fang, Ye Zeng-Chun, Li Can-Ming, Luo Peng-Li, Li Ming, Lou Tan-Qi
Department of Internal Medicine, Division of Nephrology, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China.
Department of Internal Medicine, Division of Nephrology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China.
Mol Med Rep. 2014 Feb;9(2):450-6. doi: 10.3892/mmr.2013.1855. Epub 2013 Dec 10.
Activation of the intrarenal renin‑angiotensin system (RAS), which has been identified in podocytes and mesangial cells, is a novel mechanism in the progression of diabetic kidney disease (DKD). The present study aimed to identify the local RAS in glomerular endothelial cells (GEnCs). Rat GEnCs were stimulated by culture medium containing 30 mmol/l glucose for 12, 24, 48 and 72 h. Angiotensin II (Ang II) concentrations in cell lysates and culture media were examined by ELISA and mRNA levels of angiotensinogen and renin in cell lysates were analyzed by quantitative polymerase chain reaction. Ang II type 1 receptor (AT1R), Ang II type 2 receptor (AT2R), renin and angiotensinogen levels in cell lysates were determined by western blot analysis. Localization of intracellular AT1R, AT2R, angiotensinogen and renin was identified by confocal immunofluorescence microscopy. Consequently, high glucose (HG) increased intracellular and extracellular Ang II levels. Captopril and chymostatin (inhibitor of chymase, an enzyme that converts Ang I to Ang II) were able to antagonize HG‑induced Ang II generation. Moreover, HG increased angiotensinogen production in GEnCs and reduced renin mRNA expression without altering renin protein production. However, HG decreased AT1R levels and resulted in AT2R shifting from the nuclear to perinuclear region in GEnCs. In conclusion, HG activated the intracellular RAS in rat GEnCs and the underlying mechanism may involve angiotensin‑converting enzyme (ACE) and non‑ACE pathways. The effects of HG on GEnCs may also involve the substrate and receptors of Ang II.
肾内肾素-血管紧张素系统(RAS)的激活已在足细胞和系膜细胞中得到证实,是糖尿病肾病(DKD)进展的一种新机制。本研究旨在确定肾小球内皮细胞(GEnCs)中的局部RAS。用含30 mmol/l葡萄糖的培养基刺激大鼠GEnCs 12、24、48和72小时。通过ELISA检测细胞裂解液和培养基中的血管紧张素II(Ang II)浓度,并用定量聚合酶链反应分析细胞裂解液中血管紧张素原和肾素的mRNA水平。通过蛋白质印迹分析确定细胞裂解液中血管紧张素II 1型受体(AT1R)、血管紧张素II 2型受体(AT2R)、肾素和血管紧张素原的水平。通过共聚焦免疫荧光显微镜确定细胞内AT1R、AT2R、血管紧张素原和肾素的定位。结果显示,高糖(HG)增加了细胞内和细胞外Ang II水平。卡托普利和糜蛋白酶抑制剂(将Ang I转化为Ang II的酶——糜酶的抑制剂)能够拮抗HG诱导的Ang II生成。此外,HG增加了GEnCs中血管紧张素原的产生,并降低了肾素mRNA表达,但不改变肾素蛋白的产生。然而,HG降低了GEnCs中AT1R水平,并导致AT2R从细胞核转移到核周区域。总之,HG激活了大鼠GEnCs中的细胞内RAS,其潜在机制可能涉及血管紧张素转换酶(ACE)和非ACE途径。HG对GEnCs的影响也可能涉及Ang II的底物和受体。